Whilst 2025 outlooks include cost impact from existing tariffs, companies have not adjusted their guidance for future ...

New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states from the European Union (EU) must work more closely together, provide ...

Health care providers accuse pharmaceutical companies of attempting to conceal their collaboration by slightly varying ...

As Southeast Asia's pharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing ...

Took a brand new Honda City from the Sector 9-based company in 2016 and refused to return it by threatening false case ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A ...

Tariffs will likely cost Deerfield-based Baxter International $60 million to $70 million this year, the company’s chief ...

Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to ...

Miguel Granda is a Founding Member of MAHA Miami, supporting Trump’s agenda to lower drug prices for Americans. He serves as ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...